Noble James 4
4 · Adaptimmune Therapeutics PLC · Filed Jul 2, 2021
Insider Transaction Report
Form 4
Noble James
DirectorChief Executive Officer
Transactions
- Award
Option to purchase Ordinary Shares
2021-07-01+379,788→ 379,788 totalExercise: $0.71From: 2022-07-01Exp: 2031-07-01→ Ordinary Shares (379,788 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.51 based on an exchange rate of $U.S. 1.3807 to GBP1.00. The actual exercise price will be the pounds sterling amount.